Background Although molecular tests are considered the reference standard for coronavirus
disease 2019 (COVID-19) diagnostics, serological and immunological tests may be useful …

Scope The aim of these guidelines is to provide evidence-based recommendations for the
assessment and management of individuals with persistent symptoms after acute COVID-19 …

Background As COVID-19 cases continue to rise globally, evidence from large randomized
controlled trials is still lacking. Currently, numerous trials testing potential treatment and …

Background Molecular and antigen point-of-care tests (POCTs) have augmented our ability
to rapidly identify and manage SARS-CoV-2 infection. However, their clinical performance …

The advent of highly sensitive molecular diagnostic techniques has improved our ability to
detect viral pathogens leading to severe and often fatal infections that require admission to …

The importance of fluid resuscitation therapy during the early stages of sepsis management
is a well-established principle. Current Surviving Sepsis Campaign (SSC) guidelines …

The aim of our study was to investigate the immunogenicity of the BNT162b2 vaccination
according to the age and medical status of vaccinated individuals. A total of 511 individuals …

Human immunodeficiency virus (HIV) infection represents a major cardiovascular risk factor,
and the cumulative cardiovascular disease (CVD) burden among aging people living with …

Background Respiratory viruses are associated with significant global morbidity and
mortality, as well as socioeconomic factors. Certain conditions and patient groups are more …

Cluster of differentiation (CD) 24, a long-known protein with multifaceted functions, has
gained attention as a possible treatment for Coronavirus Disease 19 (COVID-19) due to its …